Literature DB >> 18942750

TNF-alpha- and TRAIL-resistant glioma cells undergo autophagy-dependent cell death induced by activated microglia.

Rodrigo Mora1, Anette Abschuetz, Tim Kees, Ivana Dokic, Natalie Joschko, Susanne Kleber, Renate Geibig, Eric Mosconi, Hanswalter Zentgraf, Ana Martin-Villalba, Anne Régnier-Vigouroux.   

Abstract

The role of microglia, the brain resident macrophages, in glioma biology is still ill-defined. Despite their cytotoxic potential, these cells that significantly infiltrate the tumor mass seem to support tumor growth rather than tumor eradication. A proper activation of microglia anti-tumor activities within the tumor may provide a valuable additional arm of defense to immunotherapies against brain tumors. We herewith report a detailed characterization of (lipopolysaccharide and interferon-gamma)-induced anti-tumor activities of mouse primary microglia towards two TNF-alpha and TRAIL resistant glioma cell lines, in cell monolayer or spheroid cultures and in collagen-embedded tumor explants. Irrespective of the mouse strain, stimulated microglia secreted proteic factors that decreased proliferation and migration of these glioma cells and efficiently killed them. Death occurred specifically in glioma cells as demonstrated by the lack of toxicity of microglia supernatant towards primary cultures of astrocytes or neurons. Cell death was characterized by the early accumulation of acidic vesicles, phosphatidylserine exposure, appearance of double-membrane cytoplasmic vesicles, extensive zeiosis and a very late loss of DNA in cells that had lost membrane integrity. Inhibition of autophagosome formation efficiently protected glioma cells from death whereas caspase inhibition could only prevent DNA loss but not cytotoxicity. Death however, resulted from a blockade by microglia supernatant of the basal autophagic flux present in the glioma cells. These observations demonstrate that glioma cells resistant to apoptotic death ligands could be successfully and specifically killed through autophagy-dependent death induced by appropriately activated microglia. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18942750     DOI: 10.1002/glia.20785

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  28 in total

1.  Microglia isolated from patients with glioma gain antitumor activities on poly (I:C) stimulation.

Authors:  Tim Kees; Jennifer Lohr; Johannes Noack; Rodrigo Mora; Georg Gdynia; Grischa Tödt; Aurélie Ernst; Bernhard Radlwimmer; Christine S Falk; Christel Herold-Mende; Anne Régnier-Vigouroux
Journal:  Neuro Oncol       Date:  2011-10-20       Impact factor: 12.300

2.  Impairment of lysosomal integrity by B10, a glycosylated derivative of betulinic acid, leads to lysosomal cell death and converts autophagy into a detrimental process.

Authors:  P Gonzalez; I Mader; A Tchoghandjian; S Enzenmüller; S Cristofanon; F Basit; K-M Debatin; S Fulda
Journal:  Cell Death Differ       Date:  2012-02-17       Impact factor: 15.828

3.  Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies.

Authors:  Marie Duhamel; Mélanie Rose; Franck Rodet; Adriana Natalia Murgoci; Lea Zografidou; Anne Régnier-Vigouroux; Fabien Vanden Abeele; Firas Kobeissy; Serge Nataf; Laurent Pays; Maxence Wisztorski; Dasa Cizkova; Isabelle Fournier; Michel Salzet
Journal:  Mol Cell Proteomics       Date:  2018-03-12       Impact factor: 5.911

4.  Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells.

Authors:  Susobhan Sarkar; Axinia Döring; Franz J Zemp; Claudia Silva; Xueqing Lun; Xiuling Wang; John Kelly; Walter Hader; Mark Hamilton; Philippe Mercier; Jeff F Dunn; Dave Kinniburgh; Nico van Rooijen; Stephen Robbins; Peter Forsyth; Gregory Cairncross; Samuel Weiss; V Wee Yong
Journal:  Nat Neurosci       Date:  2013-12-08       Impact factor: 24.884

5.  Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.

Authors:  Grant W Simmons; Winnie W Pong; Ryan J Emnett; Crystal R White; Scott M Gianino; Fausto J Rodriguez; David H Gutmann
Journal:  J Neuropathol Exp Neurol       Date:  2011-01       Impact factor: 3.685

6.  Targeting A20 decreases glioma stem cell survival and tumor growth.

Authors:  Anita B Hjelmeland; Qiulian Wu; Sarah Wickman; Christine Eyler; John Heddleston; Qing Shi; Justin D Lathia; Jennifer Macswords; Jeongwu Lee; Roger E McLendon; Jeremy N Rich
Journal:  PLoS Biol       Date:  2010-02-23       Impact factor: 8.029

7.  Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy.

Authors:  Fu-Liang Bai; Yin-Hang Yu; Hui Tian; Gui-Ping Ren; Hui Wang; Bing Zhou; Xiao-Hui Han; Qing-Zhong Yu; De-Shan Li
Journal:  Cancer Biol Ther       Date:  2014-06-27       Impact factor: 4.742

Review 8.  Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors.

Authors:  Sang-Yong Lee; Christa E Müller
Journal:  Medchemcomm       Date:  2017-02-09       Impact factor: 3.597

9.  Embedded Spheroids as Models of the Cancer Microenvironment.

Authors:  Kristie M Tevis; Yolonda L Colson; Mark W Grinstaff
Journal:  Adv Biosyst       Date:  2017-08-18

10.  ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells.

Authors:  Nattinee Jantaratnotai; Hyun B Choi; James G McLarnon
Journal:  BMC Cancer       Date:  2009-12-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.